[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Red Rock Regeneration Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100611850",false,"NCT07245940","Assessing Safety of Cervical Spine Fusion With NMP®","Assessing Safety of Cervical Spine Fusion With NMP® Graft Material: A Retrospective Chart Review","Inclusion Criteria:\n\n1. Patients treated with NMP® for Cervical (C2-T1) Interbody fusion (2022-2025) at the study site.\n2. Minimum of 90-day post-operative follow up data available\n\nExclusion Criteria:\n\n* Patients with no follow-up data within 3 months from the surgery date due to missed postoperative appointments.","ALL","18 Years",{"count":18,"type":19},300,"ESTIMATED","OBSERVATIONAL","The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.",[23,24,25],"Degenerative Disc Disease","Degenerative Spondylolisthesis","Spinal Stenosis Cervical","NOT_YET_RECRUITING","2025-11-17",{"date":29,"type":30},"2025-11-24","ACTUAL",{"date":32,"type":19},"2026-01-15",{"date":34,"type":19},"2026-08-01",{"name":36,"class":37},"Red Rock Regeneration Inc.","INDUSTRY",""]